Multi-Step Dynamic Binding Model for Free Testosterone Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring free testosterone levels in diagnosing androgen disorders are flawed due to their reliance on a simplistic model of testosterone binding to sex hormone-binding globulin (SHBG), leading to inaccurate and complex calculations.
Innovation Solution
A new multi-step dynamic binding model with complex allostery is introduced, which considers the specific SHBG-testosterone binding interaction, allowing for more accurate calculation of free testosterone levels by attributing distinct interconverting microstates of the SHBG dimer and accounting for allosteric interactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If a single-step linear binding model is used to calculate free testosterone, then the calculation method is simple, but the measurement precision and reliability are poor
Solution Approach 1:
The patent segments the binding process into multiple distinct steps: (1) testosterone binding to SHBG monomer, (2) dimerization of SHBG monomers, and (3) formation of the final complex. This multi-step segmentation allows each binding event to be modeled separately with its own equilibrium constants, improving measurement accuracy while maintaining computational feasibility through systematic breakdown of the complex binding process
Solution Approach 2:
The patent introduces dynamic equilibrium relationships where binding constants are not fixed but depend on the concentration of bound testosterone. The model dynamically adjusts the apparent binding affinity based on the extent of binding, capturing the non-linear behavior of the SHBG-testosterone system. This dynamic approach resolves the contradiction by incorporating complexity only where physically necessary while simplifying calculations through established equilibrium relationships
2Reliability
If complex allostery and multiple microstates are considered in SHBG binding, then the accuracy of free testosterone calculation improves, but the computational complexity increases
Solution Approach 1:
The patent applies local quality by assigning different binding characteristics to different sites and states of the SHBG dimer. Each monomer can exist in different microstates with distinct binding properties, and the allosteric interaction between monomers is modeled with site-specific equilibrium constants. This localized differentiation improves diagnostic reliability by capturing heterogeneous binding behavior without requiring a completely complex global model
Solution Approach 2:
The patent uses the copying principle by representing the SHBG dimer as two identical monomers that can interconvert between microstates. The mathematical model copies the binding equations for each monomer and combines them systematically, reducing computational complexity through symmetry and repetition of proven sub-models rather than developing entirely new complex equations
3Measurement precision
If equilibrium dialysis is used to measure free testosterone directly, then the measurement is considered a reference method, but the experimental complexity and time requirements are high
Solution Approach 1:
The patent applies preliminary action by pre-calculating and storing the binding parameters and equilibrium relationships for the SHBG-testosterone system. The computational model is prepared in advance with all necessary constants and equations, allowing rapid calculation of free testosterone from routine clinical measurements without requiring time-consuming experimental procedures. This preliminary preparation resolves the time-accuracy contradiction by shifting complexity from the measurement phase to the model development phase
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the accuracy and reliability of measuring free testosterone levels, providing a more precise diagnostic tool for androgen disorders and improving treatment decisions.
Implementation Method 1
calculating free testosterone concentration based on the laws of mass action
Implementation Method 2
an allosteric interaction between two binding sites of the SHBG dimer
Data Source
Figure 1A~1B
Figure 2A~2B
Figure 2C
AI summary
The technology described herein is directed to the diagnosis and treatment of androgen disorders and/or deficiencies, e.g, low testosterone.